Feb 01, 2021 / 11:30PM GMT
Unidentified Company Representative -
Good morning, everyone, and thank you for joining us today for Volpara's investor briefing to discuss its acquisition of CRA Health. Joining us on the line today, as you can see on the screen is Volpara's Group CEO, Dr. Ralph Highnam; CFO, Craig Hadfield; Volpara's VP, Global Business Development, Dave Mezzoprete; as well as Dr. Brian Drohan, Chief Scientific Officer, CRA Health. (Operator Instructions) Today's briefing will include a presentation followed by a Q&A with Dr. Ralph Highnam.
(Operator Instructions) But please note, we'll be holding all questions until the end of the presentation. I'd now like to hand over to Dr. Ralph Highnam, Group CEO. Please go ahead, Ralph.
Ralph Highnam - Volpara Health Technologies Limited - MD, CEO & Director
Thank you, Sam, and welcome, everyone, to this call to give you some really exciting news. Okay, as you know, we're on a mission to save families from cancer. So I'm delighted to announce that we have acquired CRA Health, a company based up in Boston, a spinout from MGH and
Volpara Health Technologies Ltd Acquire Breast Cancer Risk Assessment Company CRA Health, LCC M&A Call Transcript
Feb 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers